Total raised
$62.2M
Last: Undisclosed 2025-05
Stage
Acquired
Founded
2004
Headcount
98
HQ
Kokhav Ya'ir Tzur Yigal
Sector
Health Tech & Life Sciences
About
BioProtect has developed a proprietary technology platform for biodegradable balloons. The technology is designed for a wide range of clinical applications, including spacing for radiation oncology protection, aesthetics, and general surgery. The company's first application in the commercialization stage is the BioProtect/ProSpace Balloon System, which acts as a spacer for the protection of healthy tissue in patients receiving radiotherapy for prostate cancer. The product is commercially available in Europe and is undergoing clinical studies in the United States prior to FDA approval. BioProtect has a robust product pipeline developed in consultation with physicians regarding radiotherapy spacing and other unmet clinical needs.
Funding history · 9 rounds · $62.2M total
2025-05
Undisclosed
Undisclosed
2020-09
Series D
$25.0M
2017-04
Series C
$4.0M
2016-06
Series B
$500K
2012-12
Series A
$2.9M
2008-06
Series A
$990K
2006-02
Series A
$700K
2004-10
Seed
$150K
Date unknown
Undisclosed
$28.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymersImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
cancersurgerybiodegradableoncologyminimally-invasivemedical-devicesdoctorshospitalsmedical-technologiestreatmentspolymersradiology